Post by Matteo Rosellini

Medical Oncologist, MD, PhD student - GU Oncology @ IRCCS Policlinico di Sant’Orsola - Azienda Ospedaliero Universitaria di Bologna

Out now on Taylor & Francis Group Expert Review of Molecular Diagnostics our brand-new review regarding KIM-1 and other interesting emerging biomarkers for adjuvant IOT in clear cell renal cell carcinoma by our young Onco GU group in IRCCS Policlinico di Sant’Orsola - Azienda Ospedaliero Universitaria di Bologna / Alma Mater Studiorum - Università di Bologna! https://lnkd.in/eYqQrzBM

Post content